BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

906 related articles for article (PubMed ID: 26282324)

  • 1. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
    Ma Q; Yang J; Li T; Milner TA; Hempstead BL
    Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Downregulation of p75
    Suelves N; Miguez A; López-Benito S; Barriga GG; Giralt A; Alvarez-Periel E; Arévalo JC; Alberch J; Ginés S; Brito V
    Mol Neurobiol; 2019 Feb; 56(2):935-953. PubMed ID: 29804232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imbalance of p75(NTR)/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies.
    Brito V; Puigdellívol M; Giralt A; del Toro D; Alberch J; Ginés S
    Cell Death Dis; 2013 Apr; 4(4):e595. PubMed ID: 23598407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. proBDNF is modified by advanced glycation end products in Alzheimer's disease and causes neuronal apoptosis by inducing p75 neurotrophin receptor processing.
    Fleitas C; Piñol-Ripoll G; Marfull P; Rocandio D; Ferrer I; Rampon C; Egea J; Espinet C
    Mol Brain; 2018 Nov; 11(1):68. PubMed ID: 30428894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Region-specific expression of precursor and mature brain-derived neurotrophic factors after chronic alcohol exposure.
    Yang JW; Ma W; Yang YL; Wang XB; Li XT; Wang TT; Wang XP; Gao W; Li JY; Zhou XF; Guo JH; Li LY
    Am J Drug Alcohol Abuse; 2017 Sep; 43(5):602-608. PubMed ID: 28032807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p75 neurotrophin receptor augments survival signaling in the striatum of pre-symptomatic Q175(WT/HD) mice.
    Wehner AB; Milen AM; Albin RL; Pierchala BA
    Neuroscience; 2016 Jun; 324():297-306. PubMed ID: 26947127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7,8-dihydroxyflavone ameliorates cognitive and motor deficits in a Huntington's disease mouse model through specific activation of the PLCγ1 pathway.
    García-Díaz Barriga G; Giralt A; Anglada-Huguet M; Gaja-Capdevila N; Orlandi JG; Soriano J; Canals JM; Alberch J
    Hum Mol Genet; 2017 Aug; 26(16):3144-3160. PubMed ID: 28541476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain.
    Ginés S; Bosch M; Marco S; Gavaldà N; Díaz-Hernández M; Lucas JJ; Canals JM; Alberch J
    Eur J Neurosci; 2006 Feb; 23(3):649-58. PubMed ID: 16487146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of BDNF and Full-Length TrkB Receptor Ameliorate Striatal Neural Survival in Huntington's Disease.
    Silva A; Naia L; Dominguez A; Ribeiro M; Rodrigues J; Vieira OV; Lessmann V; Rego AC
    Neurodegener Dis; 2015; 15(4):207-18. PubMed ID: 25896770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant Huntingtin alters retrograde transport of TrkB receptors in striatal dendrites.
    Liot G; Zala D; Pla P; Mottet G; Piel M; Saudou F
    J Neurosci; 2013 Apr; 33(15):6298-309. PubMed ID: 23575829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased BDNF Release in Cortical Neurons of a Knock-in Mouse Model of Huntington's Disease.
    Yu C; Li CH; Chen S; Yoo H; Qin X; Park H
    Sci Rep; 2018 Nov; 8(1):16976. PubMed ID: 30451892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease.
    Jin J; Peng Q; Hou Z; Jiang M; Wang X; Langseth AJ; Tao M; Barker PB; Mori S; Bergles DE; Ross CA; Detloff PJ; Zhang J; Duan W
    Hum Mol Genet; 2015 May; 24(9):2508-27. PubMed ID: 25609071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation.
    Miguez A; García-Díaz Barriga G; Brito V; Straccia M; Giralt A; Ginés S; Canals JM; Alberch J
    Hum Mol Genet; 2015 Sep; 24(17):4958-70. PubMed ID: 26063761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease.
    Zuccato C; Marullo M; Conforti P; MacDonald ME; Tartari M; Cattaneo E
    Brain Pathol; 2008 Apr; 18(2):225-38. PubMed ID: 18093249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant Drugs Correct the Imbalance Between proBDNF/p75NTR/Sortilin and Mature BDNF/TrkB in the Brain of Mice with Chronic Stress.
    Yang CR; Zhang XY; Liu Y; Du JY; Liang R; Yu M; Zhang FQ; Mu XF; Li F; Zhou L; Zhou FH; Meng FJ; Wang S; Ming D; Zhou XF
    Neurotox Res; 2020 Jan; 37(1):171-182. PubMed ID: 31493120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive axonal transport and synaptic protein changes correlate with behavioral and neuropathological abnormalities in the heterozygous Q175 KI mouse model of Huntington's disease.
    Smith GA; Rocha EM; McLean JR; Hayes MA; Izen SC; Isacson O; Hallett PJ
    Hum Mol Genet; 2014 Sep; 23(17):4510-27. PubMed ID: 24728190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Effects of Chronic Alcoholization on the Expression of Brain-Derived Neurotrophic Factor and Its Receptors in the Brains of Mice Genetically Predisposed to Depressive-Like Behavior].
    Bazovkina DV; Kondaurova EM; Tsybko AS; Kovetskaya AI; Ilchibaeva TV; Naumenko VS
    Mol Biol (Mosk); 2017; 51(4):647-655. PubMed ID: 28900083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRiC subunits enhance BDNF axonal transport and rescue striatal atrophy in Huntington's disease.
    Zhao X; Chen XQ; Han E; Hu Y; Paik P; Ding Z; Overman J; Lau AL; Shahmoradian SH; Chiu W; Thompson LM; Wu C; Mobley WC
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5655-64. PubMed ID: 27601642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VGLUT3 Deletion Rescues Motor Deficits and Neuronal Loss in the zQ175 Mouse Model of Huntington's Disease.
    Ibrahim KS; El Mestikawy S; Abd-Elrahman KS; Ferguson SSG
    J Neurosci; 2023 Jun; 43(23):4365-4377. PubMed ID: 37055181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ProBDNF/p75NTR/sortilin pathway is activated in peripheral blood of patients with alcohol dependence.
    Zhou L; Xiong J; Ruan CS; Ruan Y; Liu D; Bao JJ; Zhou XF
    Transl Psychiatry; 2018 Mar; 7(11):2. PubMed ID: 29520063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.